ARUNS PHARM LTD

Company Registration Number:
14305798 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

ARUNS PHARM LTD

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

ARUNS PHARM LTD

Balance sheet

As at 31 March 2025


Notes
2025
2024


£
£
Fixed assets
Intangible assets: 3 350,000 350,000
Total fixed assets: 350,000 350,000
Current assets
Stocks: 56,569 26,098
Debtors:   90,193 33,350
Cash at bank and in hand: 34,315 72,260
Total current assets: 181,077 131,708
Creditors: amounts falling due within one year:   (169,795) (115,770)
Net current assets (liabilities): 11,282 15,938
Total assets less current liabilities: 361,282 365,938
Creditors: amounts falling due after more than one year:   (333,474) (356,603)
Provision for liabilities: (48) (47)
Total net assets (liabilities): 27,760 9,288
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 27,660 9,188
Shareholders funds: 27,760 9,288

The notes form part of these financial statements

ARUNS PHARM LTD

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 30 November 2025
and signed on behalf of the board by:

Name: Kanagaratnam Arunan
Status: Director

The notes form part of these financial statements

ARUNS PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

ARUNS PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 7 7

ARUNS PHARM LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Intangible Assets

Total
Cost £
At 01 April 2024 350,000
At 31 March 2025 350,000
Net book value
At 31 March 2025 350,000
At 31 March 2024 350,000